Crossmark

Does the “delayed start” protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial

Crossref DOI link: https://doi.org/10.1186/s12958-018-0442-y

Published Online: 2018-12-28

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ashrafi, Mahnaz

Arabipoor, Arezoo

Yahyaei, Azar

Zolfaghari, Zahra

Ghaffari, Firouzah
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 22 September 2018

Accepted: 10 December 2018

First Online: 28 December 2018

Ethics approval and consent to participate

: The Institutional Review Boards and the Ethics Committees of Royan Institute, Tehran, Iran approved this study (ethics code: IR.ACECR.ROYAN.REC.1394.40). All procedures performed in studies involving human participants were in accordance with the ethical standards of Royan Institute and the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The eligible patients signed written informed consent prior to <i>participation in the study.</i>

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below